Synexis
PrivateLast Round
Strategic
May 18, 2021
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synexis is a biotechnology company that provides continuous pathogen control technology using patented Dry Hydrogen Peroxide (DHP) to reduce airborne and surface-level microbes in occupied spaces.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Facility Management, Smart Buildings
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synexis Comparables
Compare Synexis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Extreme Microbial Technologies | 84% | |
| The Pyure Company | 83% | |
| CASPR Technologies | 81% | |
Synexis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 18, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 30% MoM, reaching 7K.
- May 19, 2026
Monthly visitors increased 62% MoM.
Synexis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synexis's valuation, stock price, and market status.